Published in Obesity and Diabetes Week, March 9th, 2009
"The vesicular ACh transporter (VAChT) receptor has been shown to be a useful marker of cholinergic activity in vivo. The positron emission tomography (PET) radiotracer (+)-4-[F-18]fluorobenzyltrozamicol ([F-18]FBT) binds to the VAChT receptor on presynaptic cholinergic neurons and can be quantified...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.